Skip to the page

Data / Form D filings / Dash Bio, Inc.

Dash Bio, Inc.: Form D filings

Dash Bio, Inc., a health care company in Boston, MA, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on July 14, 2026, reports $30 million sold of a $30 million offering to 9 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
56 BROAD STREET STE 14011, Boston, MA, 02109
Phone
(617) 249-4472
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2041370

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 14, 2026New notice$30,000,022$30,000,0229Jun 15, 2026sec.gov
Jun 26, 2025New noticeIndefinite$10,999,97612Jun 13, 2025sec.gov
Oct 17, 2024New noticeIndefinite$6,121,00015Oct 2, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David JohnsonExecutive Officer, Director
Alexander TallettExecutive Officer, Director
Andy SmithDirector

Other health care companies in Massachusetts that filed recently

Every Form D from the week of Jul 13, 2026 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Dash Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.